» Articles » PMID: 35421595

A Review of Potential National Chronic Pain Surveillance Systems in the United States

Abstract

Pain has been established as a major public health problem in the United States (U.S.) with 50 million adults experiencing chronic pain and 20 million afflicted with high-impact chronic pain (ie, chronic pain that interferes with life or work activities). High financial and social costs are associated with chronic pain. Over the past 2 decades, pain management has been complicated by the marked increase in opioids prescribed to treat chronic noncancer pain and by the concurrent opioid crisis. Monitoring the prevalence of chronic pain and pain management is especially important because pain management is changing in uncertain ways. We review potential U.S. chronic pain surveillance systems, present potential difficulties of chronic pain surveillance, and explore how to address chronic pain surveillance in the current opioid era. We consider case definitions, severity, anatomic site, and varieties of chronic pain management strategies in reviewing and evaluating national surveys for chronic pain surveillance. Based on the criteria evaluated, the National Health Interview Survey offers the best single source for pain surveillance as the pain-related questions administered are brief, valid, and cover a broad scope of pain-related phenomena. PERSPECTIVE: This review article describes data sources that can be leveraged to conduct national chronic pain surveillance in the United States, explores case defining or pain-related questions administered, and evaluates them against 8 surveillance attributes.

Citing Articles

Chronic Pain and High-impact Chronic Pain in U.S. Adults, 2023.

Lucas J, Sohi I NCHS Data Brief. 2025; 518.

PMID: 39751180 PMC: 11726267. DOI: CS355235.


Pain in chronic liver disease compared to other chronic conditions: Results from a contemporary nationally representative cohort study.

Zhang G, Cortella A, Lai J, Rubin J Hepatol Commun. 2024; 9(1).

PMID: 39670874 PMC: 11637743. DOI: 10.1097/HC9.0000000000000605.


A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain.

Yang Y, Qiu Y, Hu J, Rosen-Zvi M, Guan Q, Cheng F Cell Rep Methods. 2024; 4(10):100865.

PMID: 39341201 PMC: 11573792. DOI: 10.1016/j.crmeth.2024.100865.


Nutritional Strategies for Chronic Craniofacial Pain and Temporomandibular Disorders: Current Clinical and Preclinical Insights.

Piriyaprasath K, Kakihara Y, Hasegawa M, Iwamoto Y, Hasegawa Y, Fujii N Nutrients. 2024; 16(17).

PMID: 39275184 PMC: 11397166. DOI: 10.3390/nu16172868.


Treatment Among Commercial and Medicaid-Insured Adults With Incident Chronic Pain Episodes.

Bohm M, Siwakoti L, Nahin R J Pain. 2024; 25(12):104667.

PMID: 39271034 PMC: 11560471. DOI: 10.1016/j.jpain.2024.104667.


References
1.
Pitcher M, Von Korff M, Bushnell M, Porter L . Prevalence and Profile of High-Impact Chronic Pain in the United States. J Pain. 2018; 20(2):146-160. PMC: 8822465. DOI: 10.1016/j.jpain.2018.07.006. View

2.
Mayhew M, DeBar L, Deyo R, Kerns R, Goulet J, Brandt C . Development and Assessment of a Crosswalk Between ICD-9-CM and ICD-10-CM to Identify Patients with Common Pain Conditions. J Pain. 2019; 20(12):1429-1445. PMC: 6874733. DOI: 10.1016/j.jpain.2019.05.006. View

3.
Turner J, Shortreed S, Saunders K, LeResche L, Berlin J, Von Korff M . Optimizing prediction of back pain outcomes. Pain. 2013; 154(8):1391-401. DOI: 10.1016/j.pain.2013.04.029. View

4.
. QuickStats: Percentage* of Adults Aged ≥20 Years Who Had Chronic Pain, by Veteran Status and Age Group - National Health Interview Survey, United States, 2019. MMWR Morb Mortal Wkly Rep. 2020; 69(47):1797. PMC: 7727604. DOI: 10.15585/mmwr.mm6947a6. View

5.
Gaskin D, Richard P . The economic costs of pain in the United States. J Pain. 2012; 13(8):715-24. DOI: 10.1016/j.jpain.2012.03.009. View